Objectives: The aim of the study was to assess the change in health related quality of life (HRQoL) after infrageniculate bypass grafting in patients with critical limb ischaemia (CLI).
Design: Observational, prospective clinical study.
Materials And Methods: In total, 86 patients (72% male; age 71 (IQR, 64-78) years) undergoing infrageniculate bypass grafting for limb salvage were assessed by the short form (SF)-36 questionnaire before and 6 months after surgery. In subgroup analysis, the influence of diabetes mellitus, age, gender, and stage of peripheral arterial occlusive disease on HRQoL-outcome were assessed.
Results: Following revascularization HRQoL significantly improved in all eight dimensions of the SF-36. While baseline HRQoL-values of diabetic and non-diabetic patients did not differ significantly, postoperative improvement was significantly less in the diabetes group.
Conclusions: An aggressive approach towards infrageniculate bypass surgery for limb salvage is justified by quality of life improvement. However, this improvement tends to be less in patients with diabetes mellitus.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejvs.2006.02.007 | DOI Listing |
Ann Vasc Surg
October 2023
Department of Surgery, Division of Vascular & Endovascular Surgery, University of California San Diego, San Diego, California, The United States of America. Electronic address:
Background: Neuraxial anesthesia (NA) has been hypothesized to decrease postoperative complications and reduce mortality. However, studies regarding the impact of anesthesia type on outcomes of infrainguinal bypass (IIB) have demonstrated mixed results. In this multi-institutional study, we aimed to investigate the association of neuraxial anesthesia (NA) versus general anesthesia (GA) and perioperative and one-year outcomes of IIBs.
View Article and Find Full Text PDFJ Vasc Surg
October 2024
Department of Surgery, George Washington University Hospital, Washington, DC.
Objective: Chronic limb-threatening ischemia (CLTI) due to isolated tibial occlusive disease is treated by either popliteal-distal bypass (PDB) or tibial angioplasty (TA), although there is limited data directly comparing efficacy and outcomes between these two treatment modalities. This study compares 30-day mortality and major adverse limb events following infrapopliteal bypass and TA in patients with CLTI.
Methods: Patients who underwent PDB for CLTI were extracted from American College of Surgeons National Surgical Quality Improvement Program targeted lower extremity open database, whereas patient with CLTI who underwent isolated TA were identified in the targeted lower extremity endovascular database.
J Vasc Surg
October 2024
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN. Electronic address:
J Vasc Surg
May 2024
Division of Vascular Surgery, Department of Surgery, New York University Langone Medical Center, New York, NY. Electronic address:
Objective: The infrageniculate popliteal artery is a potential source for inflow in lower extremity bypass surgery in patients with isolated tibial artery disease. The objective of our study was to assess the short- and long-term outcomes of popliteal-distal bypasses using data from the Vascular Quality Initiative (VQI).
Methods: The VQI registry was queried between 2003 and 2021 for patients undergoing surgical revascularizations with the below-knee popliteal artery serving as inflow.
J Vasc Surg
March 2024
Division of Vascular and Endovascular Therapy, Harrington Heart and Vascular Institute, University Hospitals, Cleveland Medical Center and Case Western Reserve University, Cleveland, OH.
Objective: There is no consensus on the optimal anticoagulant regimen following lower extremity bypass. Historically, warfarin has been utilized for prosthetic or compromised vein bypasses. Direct-acting oral anticoagulants (DOACs) are increasingly replacing warfarin in this context, but their efficacy in bypass preservation has not been well-studied.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!